To determine the benefits of rebamipide in combination with intralesional injection of hyaluronidase and dexamethasone in reducing the burning sensation in patients with oral submucous fibrosis
Not Applicable
- Conditions
- Health Condition 1: D103- Benign neoplasm of other and unspecified parts of mouthHealth Condition 2: K135- Oral submucous fibrosis
- Registration Number
- CTRI/2020/03/024382
- Lead Sponsor
- GMOGESHVAAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with vertical fibrous bands in the oral cavity and histopathologically proven oral submucous fibrosis.
Grade 2 and grade 3 oral submucous fibrosis
Exclusion Criteria
Grade 1 and grade 4 oral submucous fibrosis
Patients who refuse to quit the tobacco chewing habit
Uncooperative patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method